Cargando…

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders

BACKGROUND: The gonadotrophin-releasing hormone (GnRH) antagonist protocol has some advantages, such as a simple method, short medication duration, and low incidence of ovarian hyperstimulation syndrome, but whether the GnRH antagonist protocol is suitable for normal ovarian responders has been cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Min, Zheng, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112052/ https://www.ncbi.nlm.nih.gov/pubmed/33975553 http://dx.doi.org/10.1186/s12884-021-03849-8

Ejemplares similares

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization
por: Lee, Kyung-Hee, et al.
Publicado: (2014)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
por: Rosario, Derek J., et al.
Publicado: (2016)

Review of Implant Gonadotrophin-Releasing Hormone Agonist Use: Experience in a Single Academic Center
por: Ni, Jennifer, et al.
Publicado: (2023)

Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility
por: Wang, Yizhuo, et al.
Publicado: (2022)

Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function
por: Armstrong, S.P., et al.
Publicado: (2011)

Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids
por: Kim, Eun Hee, et al.
Publicado: (2014)

Temporal and Spatial Regulation of CRE Recombinase Expression in Gonadotrophin-Releasing Hormone Neurones in the Mouse
por: Wolfe, A, et al.
Publicado: (2008)

Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
por: Bahaeldein, E, et al.
Publicado: (2018)

The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments
por: Anckaert, Ellen, et al.
Publicado: (2012)

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors.
por: Qayum, A., et al.
Publicado: (1990)

Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study
por: Chou, Szu-Yuan, et al.
Publicado: (2020)

Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis
por: Chan, Jeffrey S. K., et al.
Publicado: (2022)

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts
por: Jacobs, E, et al.
Publicado: (1999)

Research Note: Polymorphisms of gonadotrophin-releasing hormone gene and their association with growth traits in quail (Coturnix Coturnix)
por: Wang, Xinle, et al.
Publicado: (2022)

Effectiveness of gonadotrophin-releasing hormone agonist therapy to improve the outcomes of intrauterine insemination in patients suffering from stage I-II endometriosis
por: Zhang, Kemei, et al.
Publicado: (2022)

Orthotopic Transplantation of Cryopreserved Mouse Ovaries and Gonadotrophin Releasing Hormone Analogues in the Restoration of Function following Chemotherapy-Induced Ovarian Damage
por: Li, Qing, et al.
Publicado: (2015)

Gonadotrophins: The future
por: Patil, Madhuri
Publicado: (2014)

Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice
por: Rima, Umme K., et al.
Publicado: (2018)

Interplay between nitric oxide and gonadotrophin-releasing hormone in the neuromodulation of the corpus luteum during late pregnancy in the rat
por: Vallcaneras, Sandra, et al.
Publicado: (2022)

The correlation of anandamide with gonadotrophin and sex steroid hormones during the menstrual cycle
por: Cui, Na, et al.
Publicado: (2017)

Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature
por: Triviño, Vanessa, et al.
Publicado: (2019)

Gonadotrophin-Releasing Hormone (GnRH) Analogues in the Treatment of Mixed Mullerian Tumours of the Uterus: Two Case Reports and Review
por: Katesmark, Michael, et al.
Publicado: (1998)

Human Gonadotrophin Secretion
por: Franchimont, P.
Publicado: (1972)

The Effect of Lupinus albus on Growth Performance, Body Composition and Satiety Hormones of Male Pigs Immunized against Gonadotrophin Releasing Factor
por: Moore, Karen, et al.
Publicado: (2017)

Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
por: Ansari, Mohammad Abdul Jalil, et al.
Publicado: (2008)

Human Chorionic Gonadotrophin: New Pleiotropic Functions for an “Old” Hormone During Pregnancy
por: Gridelet, Virginie, et al.
Publicado: (2020)

RF33 | PSUN04 Luteinizing Hormone-Chorionic Gonadotrophin Receptor in Pheochromocytomas
por: Lopez, Antoine-Guy, et al.
Publicado: (2022)

Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation
por: Morte, Carles, et al.
Publicado: (2017)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
por: Rabati, Behnaz Khani, et al.
Publicado: (2012)

Influence of human chorionic gonadotrophin during ovarian stimulation: an overview
por: Smitz, Johan, et al.
Publicado: (2020)

Gonadotrophin abnormalities in an infant with Lowe syndrome
por: Warner, Bronwen E, et al.
Publicado: (2017)

The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study
por: Amer, Saad A, et al.
Publicado: (2013)

Comparison of Clinical Efficacy between a Single Administration of Long-Acting Gonadotrophin-Releasing Hormone Agonist (GnRHa) and Daily Administrations of Short-Acting GnRHa in In Vitro Fertilization-Embryo Transfer Cycles
por: Cheon, Kang Woo, et al.
Publicado: (2008)

Poor Ovarian Response to Gonadotrophins in PCOS Women after Laparoscopic Ovarian Drilling
por: Burnik Papler, Tanja, et al.
Publicado: (2022)

Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
por: Ji, Hui, et al.
Publicado: (2022)

Luteinising hormone-based protocol versus traditional flexible gonadotropin-releasing hormone antagonist protocol in women with normal ovarian response: study protocol for a non-inferiority trial
por: Lv, Ya-su, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oebolov5kkjl4rle4vgg5p2gao